# Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.

> **NCT06856967** · — · RECRUITING · sponsor: **Meyer Children's Hospital IRCCS** · enrollment: 138 (estimated)

## Conditions studied

- Respiratory Synctial Virus Infections

## Interventions

- **DRUG:** Nirsevimab

## Key facts

- **NCT ID:** NCT06856967
- **Lead sponsor:** Meyer Children's Hospital IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-04
- **Primary completion:** 2025-03
- **Final completion:** 2025-04
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06856967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06856967, "Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06856967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*